Chemfab Alkalis allots ESOP shares, reports Q2 2025 results

On October 31, 2025, Chemfab Alkalis Limited announced the allotment of 6,000 equity shares of Rs.10/- each to an employee who exercised options under the Chemfab Alkalis Employees Stock Options Scheme ("CAESOS 2020"). This allotment increases the total issued equity shares to 14,373,702 and total issued share capital to Rs.14,37,37,020/-. The exercise price per share was Rs.97.83/-, including a premium of Rs.87.83/- per share.

The board also approved the unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2025. For the six months ended September 30, 2025, standalone total income reached Rs.16,039.09 Lakhs with a net profit after tax of Rs.698.62 Lakhs. Consolidated total income for the same period was Rs.17,122.21 Lakhs, with a net profit after tax of Rs.53.69 Lakhs.

The company further reported that 4,000 equity shares were allotted under the CAESOS 2020 scheme during the half-year ended September 30, 2025. The sale of Salt Division 2, aggregating to Rs.2165.04 Lakhs, is expected to be completed before the end of the financial year.